All News

2019

July

Media Release / Jul 18, 2019

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read More
Media Release / Jul 02, 2019

Sandoz launches oncology generic gefitinib in 13 EU countries at loss of market exclusivity, expanding access to essential medicine

Read More

June

Sickle cell disease patient, Nana, poses in Ghana to share her story
Featured News / Jun 19, 2019

World Sickle Cell Day 2019

For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.

Read More
Media Release / Jun 14, 2019

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More
Media Release / Jun 07, 2019

Novartis announces new leader of Pharmaceuticals Business Unit

Read More
Media Release / Jun 06, 2019

Advanced Accelerator Applications Receives Positive CHMP Opinion for LysaKare®

Read More
Media Release / Jun 04, 2019

Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar® + Mekinist®

Read More
Media Release / Jun 03, 2019

Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials

Read More
Media Release / Jun 01, 2019

Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial

Read More

May

Senior Vice President & Franchise Head at Novartis Oncology shares her story for “Women in Science.”
Story / May 29, 2019

Women in Science: Shannon Campbell

How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More